nodes	percent_of_prediction	percent_of_DWPC	metapath
Atracurium—Hypoxemia—Vinorelbine—ovarian cancer	0.0932	0.0932	CcSEcCtD
Atracurium—Hypoxia—Vinorelbine—ovarian cancer	0.0294	0.0294	CcSEcCtD
Atracurium—Convulsion—Altretamine—ovarian cancer	0.0262	0.0262	CcSEcCtD
Atracurium—Anaphylactoid reaction—Topotecan—ovarian cancer	0.0164	0.0164	CcSEcCtD
Atracurium—Cardiac arrest—Topotecan—ovarian cancer	0.0151	0.0151	CcSEcCtD
Atracurium—Cardiac arrest—Melphalan—ovarian cancer	0.0148	0.0148	CcSEcCtD
Atracurium—Bronchospasm—Melphalan—ovarian cancer	0.0132	0.0132	CcSEcCtD
Atracurium—Wheezing—Paclitaxel—ovarian cancer	0.0122	0.0122	CcSEcCtD
Atracurium—Muscular weakness—Vinorelbine—ovarian cancer	0.012	0.012	CcSEcCtD
Atracurium—Bronchospasm—Vinorelbine—ovarian cancer	0.0115	0.0115	CcSEcCtD
Atracurium—Connective tissue disorder—Melphalan—ovarian cancer	0.0106	0.0106	CcSEcCtD
Atracurium—Flushing—Melphalan—ovarian cancer	0.00997	0.00997	CcSEcCtD
Atracurium—Angiopathy—Topotecan—ovarian cancer	0.00996	0.00996	CcSEcCtD
Atracurium—Injury—Paclitaxel—ovarian cancer	0.00993	0.00993	CcSEcCtD
Atracurium—Immune system disorder—Topotecan—ovarian cancer	0.00991	0.00991	CcSEcCtD
Atracurium—Mediastinal disorder—Topotecan—ovarian cancer	0.00989	0.00989	CcSEcCtD
Atracurium—Angioedema—Chlorambucil—ovarian cancer	0.00981	0.00981	CcSEcCtD
Atracurium—Immune system disorder—Melphalan—ovarian cancer	0.00971	0.00971	CcSEcCtD
Atracurium—Mediastinal disorder—Melphalan—ovarian cancer	0.00969	0.00969	CcSEcCtD
Atracurium—Convulsion—Chlorambucil—ovarian cancer	0.0093	0.0093	CcSEcCtD
Atracurium—Connective tissue disorder—Vinorelbine—ovarian cancer	0.00923	0.00923	CcSEcCtD
Atracurium—Angioedema—Topotecan—ovarian cancer	0.00873	0.00873	CcSEcCtD
Atracurium—Flushing—Vinorelbine—ovarian cancer	0.00871	0.00871	CcSEcCtD
Atracurium—Cardiac arrest—Paclitaxel—ovarian cancer	0.00868	0.00868	CcSEcCtD
Atracurium—Angiopathy—Vinorelbine—ovarian cancer	0.00852	0.00852	CcSEcCtD
Atracurium—Immune system disorder—Vinorelbine—ovarian cancer	0.00848	0.00848	CcSEcCtD
Atracurium—Mediastinal disorder—Vinorelbine—ovarian cancer	0.00846	0.00846	CcSEcCtD
Atracurium—Cardiovascular disorder—Epirubicin—ovarian cancer	0.00818	0.00818	CcSEcCtD
Atracurium—Erythema—Vinorelbine—ovarian cancer	0.00817	0.00817	CcSEcCtD
Atracurium—Convulsion—Melphalan—ovarian cancer	0.00811	0.00811	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.00808	0.00808	CcSEcCtD
Atracurium—Muscular weakness—Paclitaxel—ovarian cancer	0.00805	0.00805	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.00791	0.00791	CcSEcCtD
Atracurium—Anaphylactic shock—Topotecan—ovarian cancer	0.0078	0.0078	CcSEcCtD
Atracurium—Nervous system disorder—Topotecan—ovarian cancer	0.00765	0.00765	CcSEcCtD
Atracurium—Anaphylactic shock—Melphalan—ovarian cancer	0.00764	0.00764	CcSEcCtD
Atracurium—Skin disorder—Topotecan—ovarian cancer	0.00757	0.00757	CcSEcCtD
Atracurium—Cardiovascular disorder—Doxorubicin—ovarian cancer	0.00757	0.00757	CcSEcCtD
Atracurium—Angioedema—Vinorelbine—ovarian cancer	0.00747	0.00747	CcSEcCtD
Atracurium—Tachycardia—Melphalan—ovarian cancer	0.00745	0.00745	CcSEcCtD
Atracurium—Skin disorder—Melphalan—ovarian cancer	0.00742	0.00742	CcSEcCtD
Atracurium—Hypotension—Melphalan—ovarian cancer	0.00713	0.00713	CcSEcCtD
Atracurium—Hypertension—Vinorelbine—ovarian cancer	0.00706	0.00706	CcSEcCtD
Atracurium—Urticaria—Chlorambucil—ovarian cancer	0.00696	0.00696	CcSEcCtD
Atracurium—Dyspnoea—Topotecan—ovarian cancer	0.00695	0.00695	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.00691	0.00691	CcSEcCtD
Atracurium—Dyspnoea—Melphalan—ovarian cancer	0.00681	0.00681	CcSEcCtD
Atracurium—Anaphylactic shock—Vinorelbine—ovarian cancer	0.00667	0.00667	CcSEcCtD
Atracurium—Bronchospasm—Docetaxel—ovarian cancer	0.00658	0.00658	CcSEcCtD
Atracurium—Nervous system disorder—Vinorelbine—ovarian cancer	0.00654	0.00654	CcSEcCtD
Atracurium—Tachycardia—Vinorelbine—ovarian cancer	0.00651	0.00651	CcSEcCtD
Atracurium—Skin disorder—Vinorelbine—ovarian cancer	0.00648	0.00648	CcSEcCtD
Atracurium—Hypersensitivity—Chlorambucil—ovarian cancer	0.00645	0.00645	CcSEcCtD
Atracurium—Bradycardia—Paclitaxel—ovarian cancer	0.00643	0.00643	CcSEcCtD
Atracurium—Hypotension—Vinorelbine—ovarian cancer	0.00623	0.00623	CcSEcCtD
Atracurium—Connective tissue disorder—Paclitaxel—ovarian cancer	0.00621	0.00621	CcSEcCtD
Atracurium—Pruritus—Chlorambucil—ovarian cancer	0.0062	0.0062	CcSEcCtD
Atracurium—Urticaria—Topotecan—ovarian cancer	0.00619	0.00619	CcSEcCtD
Atracurium—Urticaria—Melphalan—ovarian cancer	0.00607	0.00607	CcSEcCtD
Atracurium—Dyspnoea—Vinorelbine—ovarian cancer	0.00595	0.00595	CcSEcCtD
Atracurium—Flushing—Paclitaxel—ovarian cancer	0.00586	0.00586	CcSEcCtD
Atracurium—Hypersensitivity—Topotecan—ovarian cancer	0.00575	0.00575	CcSEcCtD
Atracurium—Angiopathy—Paclitaxel—ovarian cancer	0.00573	0.00573	CcSEcCtD
Atracurium—Immune system disorder—Paclitaxel—ovarian cancer	0.0057	0.0057	CcSEcCtD
Atracurium—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00569	0.00569	CcSEcCtD
Atracurium—Hypersensitivity—Melphalan—ovarian cancer	0.00563	0.00563	CcSEcCtD
Atracurium—Pruritus—Topotecan—ovarian cancer	0.00552	0.00552	CcSEcCtD
Atracurium—Erythema—Paclitaxel—ovarian cancer	0.0055	0.0055	CcSEcCtD
Atracurium—Pruritus—Melphalan—ovarian cancer	0.0054	0.0054	CcSEcCtD
Atracurium—Anaphylactoid reaction—Epirubicin—ovarian cancer	0.00539	0.00539	CcSEcCtD
Atracurium—Urticaria—Vinorelbine—ovarian cancer	0.0053	0.0053	CcSEcCtD
Atracurium—Connective tissue disorder—Docetaxel—ovarian cancer	0.00526	0.00526	CcSEcCtD
Atracurium—Angioedema—Paclitaxel—ovarian cancer	0.00502	0.00502	CcSEcCtD
Atracurium—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.00499	0.00499	CcSEcCtD
Atracurium—Flushing—Docetaxel—ovarian cancer	0.00497	0.00497	CcSEcCtD
Atracurium—Cardiac arrest—Epirubicin—ovarian cancer	0.00496	0.00496	CcSEcCtD
Atracurium—Rash—Topotecan—ovarian cancer	0.00492	0.00492	CcSEcCtD
Atracurium—Hypersensitivity—Vinorelbine—ovarian cancer	0.00491	0.00491	CcSEcCtD
Atracurium—Dermatitis—Topotecan—ovarian cancer	0.00491	0.00491	CcSEcCtD
Atracurium—Angiopathy—Docetaxel—ovarian cancer	0.00486	0.00486	CcSEcCtD
Atracurium—Immune system disorder—Docetaxel—ovarian cancer	0.00484	0.00484	CcSEcCtD
Atracurium—Mediastinal disorder—Docetaxel—ovarian cancer	0.00482	0.00482	CcSEcCtD
Atracurium—Rash—Melphalan—ovarian cancer	0.00481	0.00481	CcSEcCtD
Atracurium—Dermatitis—Melphalan—ovarian cancer	0.00481	0.00481	CcSEcCtD
Atracurium—Convulsion—Paclitaxel—ovarian cancer	0.00476	0.00476	CcSEcCtD
Atracurium—Hypertension—Paclitaxel—ovarian cancer	0.00475	0.00475	CcSEcCtD
Atracurium—Pruritus—Vinorelbine—ovarian cancer	0.00472	0.00472	CcSEcCtD
Atracurium—Erythema—Docetaxel—ovarian cancer	0.00466	0.00466	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.00465	0.00465	CcSEcCtD
Atracurium—Muscular weakness—Epirubicin—ovarian cancer	0.0046	0.0046	CcSEcCtD
Atracurium—Cardiac arrest—Doxorubicin—ovarian cancer	0.00459	0.00459	CcSEcCtD
Atracurium—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00449	0.00449	CcSEcCtD
Atracurium—Nervous system disorder—Paclitaxel—ovarian cancer	0.0044	0.0044	CcSEcCtD
Atracurium—Tachycardia—Paclitaxel—ovarian cancer	0.00438	0.00438	CcSEcCtD
Atracurium—Skin disorder—Paclitaxel—ovarian cancer	0.00436	0.00436	CcSEcCtD
Atracurium—Muscular weakness—Doxorubicin—ovarian cancer	0.00426	0.00426	CcSEcCtD
Atracurium—Rash—Vinorelbine—ovarian cancer	0.00421	0.00421	CcSEcCtD
Atracurium—Dermatitis—Vinorelbine—ovarian cancer	0.0042	0.0042	CcSEcCtD
Atracurium—Hypotension—Paclitaxel—ovarian cancer	0.00419	0.00419	CcSEcCtD
Atracurium—Convulsion—Docetaxel—ovarian cancer	0.00404	0.00404	CcSEcCtD
Atracurium—Hypertension—Docetaxel—ovarian cancer	0.00402	0.00402	CcSEcCtD
Atracurium—Dyspnoea—Paclitaxel—ovarian cancer	0.004	0.004	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00394	0.00394	CcSEcCtD
Atracurium—Anaphylactic shock—Docetaxel—ovarian cancer	0.0038	0.0038	CcSEcCtD
Atracurium—Nervous system disorder—Docetaxel—ovarian cancer	0.00373	0.00373	CcSEcCtD
Atracurium—Tachycardia—Docetaxel—ovarian cancer	0.00371	0.00371	CcSEcCtD
Atracurium—Skin disorder—Docetaxel—ovarian cancer	0.00369	0.00369	CcSEcCtD
Atracurium—Bradycardia—Epirubicin—ovarian cancer	0.00368	0.00368	CcSEcCtD
Atracurium—Urticaria—Paclitaxel—ovarian cancer	0.00356	0.00356	CcSEcCtD
Atracurium—Hypotension—Docetaxel—ovarian cancer	0.00355	0.00355	CcSEcCtD
Atracurium—Connective tissue disorder—Epirubicin—ovarian cancer	0.00355	0.00355	CcSEcCtD
Atracurium—Bradycardia—Doxorubicin—ovarian cancer	0.0034	0.0034	CcSEcCtD
Atracurium—Dyspnoea—Docetaxel—ovarian cancer	0.00339	0.00339	CcSEcCtD
Atracurium—Flushing—Epirubicin—ovarian cancer	0.00335	0.00335	CcSEcCtD
Atracurium—Hypersensitivity—Paclitaxel—ovarian cancer	0.00331	0.00331	CcSEcCtD
Atracurium—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00328	0.00328	CcSEcCtD
Atracurium—Angiopathy—Epirubicin—ovarian cancer	0.00328	0.00328	CcSEcCtD
Atracurium—Immune system disorder—Epirubicin—ovarian cancer	0.00326	0.00326	CcSEcCtD
Atracurium—Mediastinal disorder—Epirubicin—ovarian cancer	0.00325	0.00325	CcSEcCtD
Atracurium—Pruritus—Paclitaxel—ovarian cancer	0.00317	0.00317	CcSEcCtD
Atracurium—Erythema—Epirubicin—ovarian cancer	0.00314	0.00314	CcSEcCtD
Atracurium—Flushing—Doxorubicin—ovarian cancer	0.0031	0.0031	CcSEcCtD
Atracurium—Angiopathy—Doxorubicin—ovarian cancer	0.00303	0.00303	CcSEcCtD
Atracurium—Immune system disorder—Doxorubicin—ovarian cancer	0.00302	0.00302	CcSEcCtD
Atracurium—Mediastinal disorder—Doxorubicin—ovarian cancer	0.00301	0.00301	CcSEcCtD
Atracurium—Erythema—Doxorubicin—ovarian cancer	0.00291	0.00291	CcSEcCtD
Atracurium—Rash—Paclitaxel—ovarian cancer	0.00283	0.00283	CcSEcCtD
Atracurium—Dermatitis—Paclitaxel—ovarian cancer	0.00283	0.00283	CcSEcCtD
Atracurium—Hypersensitivity—Docetaxel—ovarian cancer	0.0028	0.0028	CcSEcCtD
Atracurium—Convulsion—Epirubicin—ovarian cancer	0.00272	0.00272	CcSEcCtD
Atracurium—Hypertension—Epirubicin—ovarian cancer	0.00271	0.00271	CcSEcCtD
Atracurium—Pruritus—Docetaxel—ovarian cancer	0.00269	0.00269	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00266	0.00266	CcSEcCtD
Atracurium—Anaphylactic shock—Epirubicin—ovarian cancer	0.00257	0.00257	CcSEcCtD
Atracurium—Convulsion—Doxorubicin—ovarian cancer	0.00252	0.00252	CcSEcCtD
Atracurium—Nervous system disorder—Epirubicin—ovarian cancer	0.00252	0.00252	CcSEcCtD
Atracurium—Hypertension—Doxorubicin—ovarian cancer	0.00251	0.00251	CcSEcCtD
Atracurium—Tachycardia—Epirubicin—ovarian cancer	0.0025	0.0025	CcSEcCtD
Atracurium—Skin disorder—Epirubicin—ovarian cancer	0.00249	0.00249	CcSEcCtD
Atracurium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00246	0.00246	CcSEcCtD
Atracurium—Rash—Docetaxel—ovarian cancer	0.0024	0.0024	CcSEcCtD
Atracurium—Hypotension—Epirubicin—ovarian cancer	0.0024	0.0024	CcSEcCtD
Atracurium—Dermatitis—Docetaxel—ovarian cancer	0.0024	0.0024	CcSEcCtD
Atracurium—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00237	0.00237	CcSEcCtD
Atracurium—Nervous system disorder—Doxorubicin—ovarian cancer	0.00233	0.00233	CcSEcCtD
Atracurium—Tachycardia—Doxorubicin—ovarian cancer	0.00232	0.00232	CcSEcCtD
Atracurium—Skin disorder—Doxorubicin—ovarian cancer	0.00231	0.00231	CcSEcCtD
Atracurium—Dyspnoea—Epirubicin—ovarian cancer	0.00229	0.00229	CcSEcCtD
Atracurium—Hypotension—Doxorubicin—ovarian cancer	0.00222	0.00222	CcSEcCtD
Atracurium—Dyspnoea—Doxorubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Atracurium—Urticaria—Epirubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Atracurium—Hypersensitivity—Epirubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Atracurium—Urticaria—Doxorubicin—ovarian cancer	0.00189	0.00189	CcSEcCtD
Atracurium—Pruritus—Epirubicin—ovarian cancer	0.00181	0.00181	CcSEcCtD
Atracurium—Hypersensitivity—Doxorubicin—ovarian cancer	0.00175	0.00175	CcSEcCtD
Atracurium—Pruritus—Doxorubicin—ovarian cancer	0.00168	0.00168	CcSEcCtD
Atracurium—Rash—Epirubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Atracurium—Dermatitis—Epirubicin—ovarian cancer	0.00162	0.00162	CcSEcCtD
Atracurium—Rash—Doxorubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
Atracurium—Dermatitis—Doxorubicin—ovarian cancer	0.0015	0.0015	CcSEcCtD
